Your browser doesn't support javascript.
loading
An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index.
Hui, Xiwu; Yuan, Can; Cao, Weirong; Ge, Wenli; Zhang, Di; Dan, Mo; Zhao, Qian; Liu, Boning; Yao, Bing.
Afiliação
  • Hui X; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Yuan C; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Cao W; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Ge W; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Zhang D; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Dan M; Pharmacology Center, CSPC Pharmaceutical Group Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Zhao Q; Pharmacology Center, CSPC Pharmaceutical Group Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Liu B; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
  • Yao B; Institute of Quality Analysis, CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, Hebei, People's Republic of China.
Onco Targets Ther ; 15: 331-343, 2022.
Article em En | MEDLINE | ID: mdl-35422630
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article